Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes

被引：21
作者：
Kim, Mi Young [1 ]
Kim, Hyeon Sook [2 ]
Choi, Nami [1 ]
Yang, Jung-Hyun [3 ]
Yoo, Young Bum [3 ]
Park, Kyoung Sik [3 ]
机构：
[1] Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, Seoul, South Korea
[2] Catholic Univ Korea, St Pauls Hosp, Dept Radiol, Seoul, South Korea
[3] Konkuk Univ, Sch Med, Med Ctr, Dept Surg, Seoul, South Korea
来源：
CLINICAL IMAGING | 2015年 / 39卷 / 06期
关键词：
Breast; Mammography; Calcification; ER; HER2; SURGICAL ADJUVANT BREAST; INTRADUCTAL-CARCINOMA; PATHOLOGICAL FINDINGS; CONSERVING THERAPY; ESTROGEN-RECEPTOR; RISK-FACTORS; RECURRENCE; EVENTS; UPDATE; TRIAL;
D O I：
10.1016/j.clinimag.2015.06.006
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
We evaluated the mammographic and histopathologic features of screening mammography-detected ductal carcinoma in situ (DCIS) based on the breast cancer subtypes determined by immunohistochemistry. A total of 94 patients with 94 screening mammography-detected DCIS were included in this study. Mammographically, human epidermal growth factor receptor 2 (HER2)-positive DCIS was more commonly associated with calcifications than estrogen receptor (ER)-positive and triple-negative DCIS (P=.003). Histopathologically, HER2-positive DCIS and triple-negative DCIS were associated with high nuclear grade (P <=.001) and comedo necrosis (P <=.001) than ER-positive DCIS. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码：983 / 986
页数：4
相关论文
共 26 条
[1]  
Allred D. Craig, 2010, Journal of the National Cancer Institute Monographs, P134, DOI 10.1093/jncimonographs/lgq035
[2]  
American College of Radiology, 2013, ILL BREAST IM REP DA
[3]   Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status [J].
Bae, Min Sun ;
Moon, Woo Kyung ;
Chang, Jung Min ;
Cho, Nariya ;
Park, So Yeon ;
Won, Jae-Kyung ;
Jeon, Yoon-Kyung ;
Moon, Hyeong-Gon ;
Han, Wonshik ;
Park, In Ae .
EUROPEAN RADIOLOGY, 2013, 23 (08) :2072-2078
[4]   Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853 [J].
Bijker, N ;
Peterse, JL ;
Duchateau, L ;
Julien, JP ;
Fentiman, IS ;
Duval, C ;
Di Palma, S ;
Simony-Lafontaine, J ;
de Mascarel, I ;
van de Vijver, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2263-2271
[5]   Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast [J].
de Roos, Marnix A. ;
van der Vegt, Bert ;
de Vries, Jaap ;
Wesseling, Jelle ;
de Bock, Geertruida H. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (07) :2097-2104
[6]   DUCTAL CARCINOMA IN-SITU OF THE BREAST - CORRELATION BETWEEN MAMMOGRAPHIC AND PATHOLOGICAL FINDINGS [J].
EVANS, A ;
PINDER, S ;
WILSON, R ;
SIBBERING, M ;
POLLER, D ;
ELSTON, C ;
ELLIS, I .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (06) :1307-1311
[7]   Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience [J].
Fisher, B ;
Land, S ;
Mamounas, E ;
Dignam, J ;
Fisher, ER ;
Wolmark, N .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :400-418
[8]   Pathologic variables predictive of breast events in patients with ductal carcinoma in situ [J].
Fisher, Edwin R. ;
Land, Stephanie R. ;
Saad, Reda S. ;
Fisher, Bernard ;
Wickerham, D. Lawrence ;
Wang, Meihua ;
Costantino, Joseph P. ;
Wolmark, Norman .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (01) :86-91
[9]  
Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO
[10]  
2-Y
123